col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


330 Results       Page 1

 [1] 
Elsevier: Journal of Infection and Chemotherapy
  original article Date Title Authors   All Authors
1 [GO] 2024―Dec―30 In vitro to clinical efficacy: Neutralizing antibodies against severe acute respiratory syndrome coronavirus 2 strains Masaki Kakimoto, Toshihito Nomura, Tanuza Nazmul, Akima Yamamoto, Kotaro Ikeda, Daisuke Miyamori, et al. (+8)
2 [GO] 2024―Dec―26 Impact of Coronavirus Disease 2019 Emergency Declarations on Surgeries for Deep Neck Infection Incidence in Japan Kensuke Uraguchi, Naomi Matsumoto, Shohei Fujimoto, Takashi Yorifuji, Mizuo Ando
3 [GO] 2024―Dec―12 Molnupiravir for high-risk adults with COVID-19: target trial emulation in a Japanese cohort Yuya Kimura, Hiroki Matsui, Sachiko Ono, So Sato, Hideo Yasunaga
4 [GO] 2024―Dec―10 Trends in endemic of respiratory syncytial virus infection during COVID-19 pandemic and difficulty in obtaining optimal timing of palivizumab prophylaxis Keisuke Taku, Shun Ichikawa, Masato Ogawa, Takayuki Kokubo, Toshihiko Manabe, Kenichi Takano, et al. (+8)
5 [GO] 2024―Dec―06 Treatment patterns and clinical outcomes of immunocompromised patients with COVID-19 receiving remdesivir in the inpatient setting in Japan Manami Yoshida, Nao Taguchi, Yi Piao, Rikisha Gupta, Jami Peters, Mazin Abdelghany, et al. (+4)
6 [GO] 2024―Dec―06 Antibody titer trends after SARS-CoV-2 vaccination in patients aged 12 to 25 years with underlying diseases Taketo Kasai, Masaki Yamada, Takanori Funaki, Chiaki Tao, Shota Myojin, Hiroyuki Aiba, et al. (+7)
7 [GO] 2024―Dec―03 Ensitrelvir for the treatment of COVID-19: Final analysis of a post-marketing surveillance from Japan Noriko Hayashi, Eri Tsukimura, Eriko Ogura
8 [GO] 2024―Nov―22 Evaluation of Legionella Diagnostic Prediction Score in patients with SARS-CoV-2 Omicron pneumonia Naoyuki Miyashita, Futoshi Higa, Yosuke Aoki, Toshiaki Kikuchi, Masafumi Seki, Kazuhiro Tateda, et al. (+4)
9 [GO] 2024―Oct―11 Symptoms of Post COVID-19 Condition and Diseases/Conditions Diagnosed After COVID-19 in Japanese Patients: A Real-world Study Using a Claims Database Satoshi Kutsuna, Ryotaro Tajima, Genta Ito, Takuji Komeda, Hideyuki Miyauchi, Yoshitake Kitanishi
10 [GO] 2024―Sep―27 90-day outcomes in patients with severe COVID-19 pneumonia treated with invasive mechanical ventilation. Masamichi Mineshita, Hiroki Nishine, Hiroshi Handa, Takeo Inoue, Yuki Ishibashi, Kimito Kawahata, et al. (+6)
11 [GO] 2024―Sep―26 The Effect of Baricitinib and Corticosteroid Compared to that of Corticosteroid Monotherapy in Severely and Critically ill Patients with COVID-19: A Japanese Multicenter Inpatient Database Study. Tomoki Mizuno, Jun Suzuki, Shota Takahashi, Haruka Imai, Hideya Itagaki, Makiko Yoshida, Shiro Endo
12 [GO] 2024―Sep―24 Tocilizumab in combination with standard of care in patients with severe COVID-19 pneumonia: efficacy and safety from a phase 3 clinical trial in Japan Nobuyoshi Mori, Toshihiro Nanki, Akihiro Hirakawa, Masaya Yamato, Yuko Kaneko, Rie Shiokawa, et al. (+3)
13 [GO] 2024―Sep―11 Comparison of clinical characteristics and severity of COVID-19 with or without viral co-infection in hospitalized children Kensuke Shoji, Yusuke Asai, Shinya Tsuzuki, Nobuaki Matsunaga, Setsuko Suzuki, Noriko Iwamoto, et al. (+3)
14 [GO] 2024―Aug―30 Characteristics of virus and antibody response in an immunocompromised patient with persistent SARS-CoV-2 infection Shunsuke Yazawa, Kei Fukuyama, Rie Kawakami, Masae Itamochi, Daiki Higashi, Noriaki Tsuji, et al. (+4)
15 [GO] 2024―Aug―27 Pharmacological Effect of Cepharanthine on SARS-CoV-2-Induced Disease in a Syrian Hamster Model Takayuki Uematsu, Reiko Takai-Todaka, Kei Haga, Hideyuki Kobayashi, Makiko Imajima, Noritada Kobayashi, et al. (+2)
16 [GO] 2024―Aug―27 Pre-clinical and clinical evaluation of a surface plasmon field-enhanced fluorescence spectroscopy (SPFS) antigen test for detecting SARS-CoV-2 Nobuyuki Ashizawa, Takahiro Takazono, Kenji Ota, Yuya Ito, Tatsuro Hirayama, Kazuaki Takeda, et al. (+18)
17 [GO] 2024―Aug―23 Facility wastewater monitoring as an effective tool for pandemic infection control: An experience in COVID-19 pandemic with long-term monitoring Shoko Tateishi, Kensuke Hamada, Noriko Emoto, Kazumi Abe, Koichi Abe, Yuki Kawasaki, et al. (+8)
18 [GO] 2024―Aug―14 A questionnaire survey of infection control measures during the coronavirus infectious disease 2019 pandemic era Tetsuya Horino, Kazuyo Ono, Erisa Sugawara, Tetsuya Matsumoto, Hiroshi Yotsuyanagi, Masaki Yoshida
19 [GO] 2024―Aug―03 SARS-CoV-2 mRNA vaccine-related myocarditis and pericarditis: An analysis of the Japanese Adverse Drug Event Report database Keisuke Takada, Kazuaki Taguchi, Masaru Samura, Yuki Igarashi, Yuko Okamoto, Yuki Enoki, et al. (+2)
20 [GO] 2024―Jul―09 Clinical characteristics and COVID-19-related outcomes of immunocompromised patients receiving tixagevimab/cilgavimab pre-exposure prophylaxis in Japan Toshibumi Taniguchi, Tomoyuki Homma, Yoichi Tamai, Yoshifumi Arita, Masakazu Fujiwara, Naho Kuroishi, et al. (+3)
21 [GO] 2024―Jul―06 Influence of easing COVID-19 strategies following downgrading of the national infectious disease category on COVID-19 occurrence among hospitalized patients in Japan Miyuki Makino, Yoshio Takesue, Yasushi Murakami, Mika Morosawa, Miki Doi, Hitoshi Ogashiwa, et al. (+4)
22 [GO] 2024―Jun―27 Incidence and Potential Risk Factors of Human Cytomegalovirus Infection in Patients with Severe and Critical Coronavirus disease 2019 Waki Imoto, Takumi Imai, Ryota Kawai, Yasutaka Ihara, Yuta Nonomiya, Hiroki Namikawa, et al. (+5)
23 [GO] 2024―May―31 Corrigendum to <’ The humoral and cellular immune responses following booster vaccination with SARS-CoV-2 mRNA in people living with human immunodeficiency virus.’> <[Journal of Infection and Chemotherapy 30 (2024) 417-422]> Yuji Matsumoto, Masayuki Murata, Azusa Ohta, Sho Yamasaki, Hiroaki Ikezaki, Kazuhiro Toyoda, Nobuyuki Shimono
24 [GO] 2024―May―21 Epidemiological study of Respiratory syncytial virus infection in adults during the pandemic of COVID-19 Nobuhiro Asai, Yuichi Shibata, Atsuko Yamada, Wataru Ohashi, Mina Takayama, Yuzuka Kawamoto, et al. (+13)
25 [GO] 2024―May―20 Investigation of severe acute respiratory syndrome coronavirus 2 infection status in solid organ transplant recipients treated with tixagevimab/cilgavimab Ririka Aihara, Keisuke Umemura, Yoshiki Katada, Shunsaku Nakagawa, Takashi Kobayashi, Etsuro Hatano, et al. (+3)
26 [GO] 2024―May―06 Corrigendum to “Long-term transition of antibody titers in healthcare workers following the first to fourth doses of mRNA COVID-19 vaccine: Comparison of two automated SARS-CoV-2 immunoassays” [J Infect Chemother 29 (2023) 534-538] Yumi Taniguchi, Koichiro Suemori, Keiko Tanaka, Ai Okamoto, Akiko Murakami, Hitoshi Miyamoto, et al. (+3)
27 [GO] 2024―Apr―16 Evaluating the Association of Body Mass Index with COVID-19 Severity and Mortality using Japanese Administrative Claims Data Waki Imoto, Yasutaka Ihara, Takumi Imai, Mitsuhiro Tamoto, Tatoi Ibuki, Koichi Yamada, et al. (+3)
28 [GO] 2024―Apr―06 Nationwide epidemiology and health resource use among children with COVID-19 in Japan Yusuke Okubo, Yosuke Nakabayashi, Kenta Ito, Kazuhiro Uda, Isao Miyairi
29 [GO] 2024―Apr―02 Changing trends in Japanese spotted fever epidemiology in Shimane, Japan: A two-decade retrospective study with emphasis on the COVID-19 pandemic era Yoshiro Hadano, Tatsuyuki Kakuma
30 [GO] 2024―Apr―01 Infectious mononucleosis due to Epstein-Barr virus reactivation in an immunocompromised 60-year-old patient with COVID-19 Naonori Harada, Ikumi Shibano, Yuto Izuta, Yusuke Kizawa, Hiroshi Shiragami, Akiko Tsumura, et al. (+2)
31 [GO] 2024―Apr―01 Effects of the induction of humoral and cellular immunity by third vaccination for SARS-CoV-2 Goh Murayama, Makio Kusaoi, Yuki Horiuchi, Yoko Tabe, Toshio Naito, Suminobu Ito, et al. (+2)
32 [GO] 2024―Mar―22 Rapid response to a COVID-19 outbreak at a nightclub in Kagoshima prefecture, Japan, in the early phase of the COVID-19 pandemic, June and July 2020: A descriptive epidemiological study Keisuke Kadokura, Hirofumi Kato, Kayoko Yoshizumi, Miyuki Kamikuri, Akira Kamenosono, Naomi Shinkawa, et al. (+5)
33 [GO] 2024―Mar―08 Zinc deficiency is a potential risk factor for COVID-19 progression to pneumonia requiring oxygen therapy Koji Fujita, Kazuki Ocho, Tomoka Kadowaki, Takashi Yorifuji, Hideharu Hagiya, Fumio Otsuka
34 [GO] 2024―Mar―05 Favipiravir for symptomatic COVID-19: A nationwide observational cohort study
35 [GO] 2024―Mar―03 Clinical evaluation of a modified SARS-CoV-2 rapid molecular assay, ID NOW ™ COVID-19 2.0 Yu Arakawa, Yoshie Nishida, Daisuke Sakanashi, Akiko Nakamura, Hirotoshi Ota, Shinji Tokuhiro, et al. (+2)
36 [GO] 2024―Feb―28 Difference in the impact of coinfections and secondary infections on antibiotic use in patients hospitalized with COVID-19 between the Omicron-dominant period and the pre-Omicron period Yasushi Murakami, Yasuhiro Nozaki, Mika Morosawa, Masanobu Toyama, Hitoshi Ogashiwa, Takashi Ueda, et al. (+3)
37 [GO] 2024―Feb―20 Safety and antibody response of the BNT162b2 SARS-CoV-2 vaccine in children aged 5-11 years with underlying diseases: A prospective observational study Takanori Funaki, Masaki Yamada, Kozue Miyake, Saki Ueno, Shota Myojin, Hiroyuki Aiba, et al. (+5)
38 [GO] 2024―Feb―15 Ensitrelvir in patients with SARS-CoV-2: A retrospective chart review Masaya Yamato, Masahiro Kinoshita, Shogo Miyazawa, Masayuki Seki, Tomoki Mizuno, Takuhiro Sonoyama
39 [GO] 2024―Feb―11 Prevalence and trends in persistent symptoms following COVID-19 in Japan: A nationwide cross-sectional survey Akane Takamatsu, Hitoshi Honda, Toshiki Miwa, Takahiro Tabuchi, Kiyosu Taniguchi, Kenji Shibuya, Yasuharu Tokuda
40 [GO] 2024―Feb―10 Detailed tracking of antigen and antibody levels during coronavirus disease 2019 treatment in an immunosuppressed patient with anti-neutrophil cytoplasmic autoantibody-associated vasculitis Toshitaka Yukishima, Kazuki Furuhashi, Kumiko Shimoyama, Takeru Taki, Chika Azuma, Kenji Yamazaki, et al. (+7)
41 [GO] 2024―Feb―06 Cost-effectiveness of nirmatrelvir/ritonavir for high-risk adult outpatients with COVID-19 in Japan Takahito Mizuno, Yu Kondo, Mikiyasu Sakai, Kenichi Saneyasu, Ryota Kojima, Yoshio Miyake
42 [GO] 2024―Feb―05 External quality assessment survey for SARS-CoV-2 nucleic acid amplification tests in clinical laboratories in Tokyo, 2021 Yoshiyuki Sugishita, Rie Moriuchi, Yoshikazu Ishii
43 [GO] 2024―Feb―02 Age dependent discrepancy between SARS-CoV-2 anti-nucleoprotein antibody and anti-RBD spike protein antibody in children reflects vaccine coverage Yasuhito Fujii, Hidetoshi Ishigaki, Isao Miyairi, Noriyasu Niizeki, Osanori Nagura, Keita Yamashita, et al. (+2)
44 [GO] 2024―Jan―17 Successful management of persistent COVID-19 using combination antiviral therapy (nirmatrelvir/ritonavir and remdesivir) and intravenous immunoglobulin transfusion in an immunocompromised host who had received CD20 depleting therapy for follicular lymphoma Taketomo Maruki, Hidetoshi Nomoto, Noriko Iwamoto, Kei Yamamoto, Masami Kurokawa, Kiyoko Iwatsuki-Horimoto, et al. (+4)
45 [GO] 2024―Jan―05 Acute acalculous cholecystitis following extended administration of nirmatrelvir/ritonavir for persistent SARS-CoV-2 infection Wataru Ito, Tatsuya Fukumori, Nao Asaoka, Natsuko Imakita, Tomoko Nishimura, Ryutaro Furukawa, et al. (+10)
46 [GO] 2023―Dec―27 Efficacy and safety of ivermectin in patients with mild COVID-19 in Japan and Thailand Hiroshige Mikamo, Satoshi Takahashi, Yuka Yamagishi, Akihiro Hirakawa, Toshiyuki Harada, Hirotaka Nagashima, et al. (+13)
47 [GO] 2023―Dec―21 SARS-CoV-2 RT-PCR as a universal screening on planned admission in asymptomatic patients Chie Yamamoto, Yoko Nukui, Keitaro Furukawa, Masashi Taniguchi, Tetsuhiro Yamano, Tohru Inaba, et al. (+5)
48 [GO] 2023―Dec―14 Cross-sectional surveillance study of long COVID in Toyonaka city, Osaka prefecture, Japan Satoshi Kutsuna, Daisuke Onozuka, Kento Asano, Katsura Matsunami, Taro Matsuoka
49 [GO] 2023―Dec―12 Assessment of the prognosis, frequency, and isolated bacteria in ventilator-associated pneumonia among patients with severe coronavirus disease 2019 pneumonia: A single-center retrospective observational study Shinichi Morimoto, Kentaro Muranishi, Yoshito Izutani, Junichi Maruyama, Reijiro Kato, Shun Ninomiya, et al. (+4)
50 [GO] 2023―Nov―23 Clinical factors associated with viral shedding time of SARS-CoV-2 Omicron variant in Japan Kentaro Akata, Kei Yamasaki, Rikuto Kohrogi, Yoko Kawakami, Yorikazu Furuya, Kohichiro Eto, et al. (+3)
51 [GO] 2023―Nov―19 Prediction of acute lung injury assessed by chest computed tomography, oxygen saturation/fraction of inspired oxygen ratio, and serum lactate dehydrogenase in patients with COVID-19 Shin Matsubara, Kazuki Sudo, Kohsuke Kushimoto, Ryogo Yoshii, Keita Inoue, Mao Kinoshita, et al. (+4)
52 [GO] 2023―Nov―17 Epidemiology of endemic human coronavirus infection during the COVID-19 pandemic Fujio Kakuya, Ryuta Terao, Hikaru Onoda, Hitoshi Okubo, Hiroaki Fujiyasu, Fumie Inyaku, et al. (+3)
53 [GO] 2023―Nov―16 The humoral and cellular immune responses following booster vaccination with SARS-CoV-2 mRNA in people living with human immunodeficiency virus Yuji Matsumoto, Masayuki Murata, Azusa Ohta, Sho Yamasaki, Hiroaki Ikezaki, Kazuhiro Toyoda, Nobuyuki Shimono
54 [GO] 2023―Nov―14 The COVIDTW2 study: Role of COVID-19 vaccination in intubated patients with COVID-19-related acute respiratory distress syndrome in Taiwan Kuan-Chun Wong, Chan-Yen Kuo, I-Shiang Tzeng, Ching-Fen Hsu, Chih-Wei Wu
55 [GO] 2023―Nov―11 Infection prevention measures and its determinants in childcare facilities during the COVID-19 pandemic: A nationwide survey (2022-2023) Yusuke Okubo, Kazuhiro Uda, Mimori Kaki, Shinobu Miyoshi, Isao Miyairi
56 [GO] 2023―Nov―10 Comparison of pneumonia severity scores for COVID-19 patients with the Omicron variant Naoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, Naoki Fukuda, Akihisa Yamura, Tomoki Ito
57 [GO] 2023―Nov―07 Levels of environmental contamination with SARS-CoV-2 in hospital rooms and salivary viral loads of patients with coronavirus disease 2019 Hidehito Matsui, Yusuke Suzuki, Sohei Nakayama, Takanori Asakura, Osamu Takeuchi, Kaori Kusatsugu, et al. (+12)
58 [GO] 2023―Nov―07 Dual anti-viral treatment for persistent COVID-19 in immunocompromised hemato-oncological patients is associated with a favorable prognosis and minor side effects Suzy E. Meijer, Ora Halutz, Amos Adler, Katya Levytskyi, Luba Tau, Michal Dekel, et al. (+19)
59 [GO] 2023―Nov―05 Clinical safety of remdesivir therapy in COVID-19 patients with renal insufficiency Somi Park, Areum Kim, Jiyoung Lee, Sung-Woon Kang, Heungsup Sung, Mi-Na Kim, et al. (+10)
60 [GO] 2023―Oct―27 Improving diagnostic performance of coronavirus disease 2019 rapid antigen testing through computer-based feedback training using open-source experimental psychology software Masato Matsuda, Kosuke Itoh, Takahiro Sugai, Yoshiki Hoshiyama, Toshiaki Kikuchi, Shuji Terai
61 [GO] 2023―Oct―20 Relevance of complement immunity with brain fog in patients with long COVID Hideharu Hagiya, Kazuki Tokumasu, Yuki Otsuka, Naruhiko Sunada, Yasuhiro Nakano, Hiroyuki Honda, et al. (+2)
62 [GO] 2023―Oct―19 A case of meningoencephalitis caused by multisystem inflammatory syndrome in adult SARS-CoV-2 infection Hajime Ikenouchi, Keisuke Suzuki, Ayumi Sato, Naoki Yamamoto, Tatsuo Miyamoto, Kaoru Endo
63 [GO] 2023―Oct―14 Two cases of systemic capillary leak syndrome associated with COVID-19 in Japan Atsushi Kosaka, Takao Goto, Takuya Washino, Naoya Sakamoto, Sentaro Iwabuchi, Fukumi Nakamura-Uchiyama
64 [GO] 2023―Oct―12 Findings from a discontinued clinical trial of favipiravir in high-risk patients with early-onset COVID-19 Satoshi Iwata, Osamu Kobayashi, Kazuyoshi Kurashima, Yohei Doi, Hiroyuki Kunishima, Masaharu Shinkai, et al. (+7)
65 [GO] 2023―Oct―05 The impact of the COVID-19 pandemic on the circulation, seasonal distribution, and research of other respiratory pathogens in Turkey Yağmur Ekenoğlu Merdan, Şafak Göktaş
66 [GO] 2023―Oct―04 Prognostic value of initial serum sodium level in predicting disease severity in patients with COVID-19: A multicenter retrospective study Tatsuhiko Hata, Tadahiro Goto, Syunsuke Yamanaka, Tatsuki Matsumoto, Osamu Yamamura, Hiroyuki Hayashi
67 [GO] 2023―Sep―27 Association between use of antipyretics and antibody titers after two doses of the BNT162b2 SARS-CoV-2 vaccine in adolescents and young adults with underlying diseases Hiroyuki Aiba, Takanori Funaki, Masaki Yamada, Kozue Miyake, Saki Ueno, Chiaki Tao, et al. (+6)
68 [GO] 2023―Sep―20 Anti-SARS-CoV-2 IgG antibody after the second and third mRNA vaccinations in staff and residents in a nursing home with a previous COVID-19 outbreak in Niigata, Japan Keita Wagatsuma, Reiko Saito, Sayaka Yoshioka, Satoru Yamazaki, Ryosuke Sato, Masako Iwaya, et al. (+4)
69 [GO] 2023―Sep―19 Seroprevalence kinetics of SARS-CoV-2 antibodies in pediatric patients visiting a hospital during COVID-19 pandemic in Japan Takehiro Hashimoto, Takaaki Yahiro, Sakirul Khan, Kazunori Kimitsuki, Masayoshi Suzuki, Tamotsu Fujimoto, et al. (+4)
70 [GO] 2023―Sep―17 Enhanced measures, including PCR-based screening and syndromic surveillance for nosocomial outbreaks of the COVID-19 Omicron variant, using descriptive epidemiology and whole-genome sequencing in a Japanese tertiary care hospital Hideki Kawamura, Shoko Arimura, Ryuichi Saida, Nao Murata, Akari Shigemi, Yuichi Kodama, et al. (+8)
71 [GO] 2023―Sep―16 Influence of the coronavirus infectious disease 2019 pandemic on infectious disease practice and infection control in Japan: A web questionnaire survey Nobuaki Mori, Hiroshige Mikamo, Hiroshi Mukae, Katsunori Yanagihara, Hiroyuki Kunishima, Junichi Sasaki, Hiroshi Yotsuyanagi
72 [GO] 2023―Sep―16 Impact of augmented renal clearance on anticoagulant therapy in critically ill patients with coronavirus disease 2019: A retrospective cohort study Ryo Kamidani, Hideshi Okada, Yuki Kawasaki, Takuto Shimada, Yuto Tamaoki, Yusuke Nakashima, et al. (+16)
73 [GO] 2023―Sep―13 Risk factors for progressing to severe COVID-19 among people living with HIV in Japan: A hospital claims database study Akio Kanazawa, Yan Yan, Mayumi Yuda, Nobuyuki Fukui, Mizue Saita, Hirotake Mori, Toshio Naito
74 [GO] 2023―Sep―13 Factors associated with IgG titers against SARS-CoV-2 spike protein after second vaccination in people living with HIV controlled with anti-retroviral therapy Kwangyeol Lee, Tetsuya Horino, Tokio Hoshina, Kenji Sawaki, Yohei Sakamoto, Makiko Miyajima, et al. (+3)
75 [GO] 2023―Sep―09 Differences in COVID-19 treatment across Japan: Analysis of the COVID-19 Registry Japan (COVIREGI-JP) Yusuke Asai, Takahisa Ohashi, Keiji Imai, Koichi Murata, Shinya Tsuzuki, Nobuaki Matsunaga, Norio Ohmagari
76 [GO] 2023―Sep―09 Ensitrelvir eradicates persistent SARS-CoV-2 infection in a follicular lymphoma patient treated with anti-CD20 antibodies Ippei Sakamaki, Eiju Negoro, Hiromichi Iwasaki, Takahiro Yamauchi
77 [GO] 2023―Sep―07 A descriptive study on the potential transmission of COVID-19 to hospitalized patients from a nursery school affiliated with it Asako Doi, Kentaro Iwata, Tatsuya Yamamoto, Akiko Ogura, Seiko Nasu, Hirokazu Kuroda, Toshikazu Hasuike
78 [GO] 2023―Sep―01 Association between rubella vaccination response and long-term immune response to severe acute respiratory syndrome coronavirus 2 after BNT162b2 vaccination Kazuhiko Nakaharai, Yasushi Nakazawa, Masaki Yoshida
79 [GO] 2023―Aug―31 Pediatric hemophagocytic lymphohistiocytosis after concomitant administration of SARS-CoV-2 vaccine and influenza vaccine Anna Kaizuka, Yusuke Tokuda, Shintaro Morooka, Yoshihiro Gocho, Takanori Funaki, Toru Uchiyama, et al. (+5)
80 [GO] 2023―Aug―08 Obesity, overweight, and severe prognosis in COVID-19 patients in Japan Tomoka Kadowaki, Naomi Matsumoto, Rumi Matsuo, Toshiharu Mitsuhashi, Ayako Sasaki, Soshi Takao, Takashi Yorifuji
81 [GO] 2023―Aug―02 A nationwide cross-sectional study using a web-based questionnaire survey of the duration of isolation of COVID-19 inpatients with cancer at Japanese cancer centers Naoya Itoh, Nana Akazawa, Hanako Kurai, Ichiro Kawamura, Keiji Okinaka, Takahiro Fujita, et al. (+7)
82 [GO] 2023―Jul―29 Safety, tolerability, and pharmacokinetics of half-life extended SARS-CoV-2-neutralizing monoclonal antibodies AZD7442 (tixagevimab/cilgavimab) in healthy Japanese adults Hiroshi Okada, Kensuke Ishikawa, Yohji Itoh, Yoshinori Noda, Takashi Eto, Venkatesh Pilla Reddy, et al. (+3)
83 [GO] 2023―Jul―26 Contribution of traditional Japanese Kampo medicines, kakkonto with shosaikotokakikyosekko, in treating patients with mild-to-moderate coronavirus disease 2019: Further analysis of a multicenter, randomized controlled trial Shin Takayama, Takao Namiki, Ryutato Arita, Rie Ono, Aikiko Kikuchi, Minoru Ohsawa, et al. (+13)
84 [GO] 2023―Jun―19 Vaccination status of COVID-19 patients followed up in the ICU in a country with heterologous vaccination policy: A multicenter national study in Turkey Süleyman Yıldırım, Erdem Erkoyun, Özcan Alpdoğan, Hüseyin Oğuz Yılmaz, Barış Yılmaz, Gül Erdal Dönmez, et al. (+30)
85 [GO] 2023―Jun―12 Clinical efficacy of remdesivir for COVID-19 in children: A propensity-score-matched analysis Kensuke Shoji, Yusuke Asai, Takayuki Akiyama, Shinya Tsuzuki, Nobuaki Matsunaga, Setsuko Suzuki, et al. (+4)
86 [GO] 2023―Jun―02 Autoimmune hemolytic anemia, COVID-19, and the importance of a complete immunohematologic evaluation Jeremy W. Jacobs
87 [GO] 2023―May―20 A pitfall of cognitive bias during the pandemic: Two cases of Plasmodium falciparum malaria coinfected or misdiagnosed with COVID-19 Haruki Mito, Ryota Hase, Hideki Ueda, Nobuaki Tsuyama, Motoki Fujii, Naoya Matsuda, et al. (+3)
88 [GO] 2023―May―18 Judicious ending of isolation based on reverse transcription-polymerase chain reaction (RT-PCR) cycle threshold only for patients with coronavirus disease 2019 (COVID-19) requiring in-hospital therapy for longer than 20 days after symptom onset Yasushi Murakami, Hitoshi Ogashiwa, Yasuhiro Nozaki, Takashi Ueda, Kazuhiko Nakajima, Mika Morosawa, et al. (+3)
89 [GO] 2023―May―15 Clinical evaluation of anterior nasal cavity swab specimens by a rapid antigen test using a GLINE-2019-nCoV Ag Kit to diagnose COVID-19 Kana Ogane, Kazuo Imai, Yuta Orihara, Masahiro Kodana, Mariko Tezuka, Nanako Matsuzaki, et al. (+7)
90 [GO] 2023―May―12 Prolonged infective SARS-CoV-2 omicron variant shedding in a patient with diffuse large B cell lymphoma successfully cleared after three courses of remdesivir Kiwamu Nakamura, Masahiro Sugiyama, Hikari Ishizuka, Tomomi Sasajima, Yoko Minakawa, Hiroko Sato, et al. (+10)
91 [GO] 2023―May―11 Efficacy of convalescent plasma therapy for COVID-19 in Japan: An open-label, randomized, controlled trial Sho Saito, Satoshi Kutsuna, Imamura Akifumi, Ryota Hase, Rentaro Oda, Junko Terada, et al. (+32)
92 [GO] 2023―Apr―13 Acute cerebellar ataxia during acute COVID-19: A case series and review of the literature Hiroyuki Takao, Hiroyuki Iijima, Rika Odagiri, Itaru Hayakawa, Chikara Ogimi
93 [GO] 2023―Apr―13 Factors affecting the sensitivity of quantitative severe acute respiratory syndrome coronavirus 2 antigen test Yuki Sato, Ryosei Murai, Ryo Kobayashi, Atsuo Togashi, Yoshihiro Fujiya, Koji Kuronuma, Satoshi Takahashi
94 [GO] 2023―Apr―10 Exacerbation of autoimmune hemolytic anemia associated with pure red cell aplasia after COVID-19: A case report Hideo Kimura, Miki Furukawa, Yutaka Shiga, Tatsuyuki Kai, Ikkoh Yasuda, Shungo Katoh, Eiichiro Sando
95 [GO] 2023―Mar―30 The first case of clade I Candida auris candidemia in a patient with COVID-19 in Japan Yusuke Ohashi, Takashi Matono, Shotaro Suzuki, Shumpei Yoshino, Mohamed Mahdi Alshahni, Aya Komori, Koichi Makimura
96 [GO] 2023―Mar―12 Evaluation of residual humoral immune response against SARS-CoV-2 by a surrogate virus neutralization test (sVNT) 9 months after BNT162b2 primary vaccination Laura Pezzati, Laura Milazzo, Giorgia Carrozzo, Cristina Kullmann, Letizia Oreni, Martina Beltrami, et al. (+6)
97 [GO] 2023―Mar―07 Prospective study of three saliva qualitative antigen testing kits for the detection of SARS-CoV-2 among mainly symptomatic patients in Japan Norihiko Terada, Yusaku Akashi, Yuto Takeuchi, Atsuo Ueda, Shigeyuki Notake, Koji Nakamura, Hiromichi Suzuki
98 [GO] 2023―Mar―07 Assessment of environmental surface contamination with SARS-CoV-2 in concert Halls and banquet rooms in Japan Hidehito Matsui, Chihiro Ueda, Eri Nakajima, Yumiko Suzuki, Harumi Endo, Miho Sugamata, et al. (+7)
99 [GO] 2023―Feb―26 Evaluation of an immunochromatography-based rapid antigen test, Inspecter Kowa SARS-CoV-2, using saliva specimens for the detection of SARS-CoV-2 Masahiro Kodana, Yuta Orihara, Mariko Tezuka, Rina Takahashi, Sakiko Noguchi, Nanako Matsuzaki, et al. (+24)
100 [GO] 2023―Feb―20 Characteristics of hospitalized COVID-19 patients with other respiratory pathogens identified by rapid diagnostic test Michiyo Suzuki, Kayoko Hayakawa, Yusuke Asai, Mari Terada, Koji Kitajima, Shinya Tsuzuki, et al. (+4)
101 [GO] 2023―Feb―14 Lung abscess as a secondary infection of COVID-19: A case report and literature review Kotaro Umamoto, Masahide Horiba
102 [GO] 2023―Feb―08 Characterization of Aspergillus spp. isolated from patients with coronavirus disease 2019 Masashi Ogawa, Makoto Niki, Waki Imoto, Akane Dobashi, Minami Imai, Naomi Takayama, et al. (+5)
103 [GO] 2023―Jan―24 Detection of outlier prefectures on the mortality due to COVID-19 in Japan Kentaro Iwata, Chisato Miyakoshi
104 [GO] 2023―Jan―22 Long-term transition of antibody titers in healthcare workers following the first to fourth doses of mRNA COVID-19 vaccine: Comparison of two automated SARS-CoV-2 immunoassays Yumi Taniguchi, Koichiro Suemori, Keiko Tanaka, Ai Okamoto, Akiko Murakami, Hitoshi Miyamoto, et al. (+3)
105 [GO] 2023―Jan―20 Diagnostic significance of secondary bacteremia in patients with COVID-19 Kensuke Nakagawara, Hirofumi Kamata, Shotaro Chubachi, Ho Namkoong, Hiromu Tanaka, Ho Lee, et al. (+93)
106 [GO] 2023―Jan―07 Association between COVID-19 vaccines and the menstrual cycle in young Japanese women Shihoko Kajiwara, Naomi Akiyama, Hisashi Baba, Michio Ohta
107 [GO] 2023―Jan―07 Are the thorax Computed Tomography findings OF ICU patients diagnosed with COVID-19 pneumonia related to the duration of hospital stay and mortality? Ümmihan Topal, Gülseren Yılmaz, Ayça Sultan Şahin
108 [GO] 2022―Dec―25 An epidemiological evaluation of COVID-19 in La paz, Bolivia Ryota Ito, Masayuki Maeda, Yumiko Takehara, Go Diego Komori, Yoshito Nishi, Kimito Kondo, et al. (+4)
109 [GO] 2022―Dec―23 Assessment of the pneumonia severity score in community-acquired and nursing and healthcare-associated pneumonia due to COVID-19 Naoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, Naoki Fukuda, Akihisa Yamura, Yoshihisa Ishiura
110 [GO] 2022―Dec―15 Validation of a specialized evaluation system for COVID-19 in Japan: A retrospective, multicenter cohort study Hiroki Furuhata, Kenji Araki
111 [GO] 2022―Dec―13 Comparison of the clinical characteristics and outcomes of Japanese patients with COVID-19 treated in primary, secondary, and tertiary care facilities Daiki Tomidokoro, Yusuke Asai, Kayoko Hayakawa, Satoshi Kutsuna, Mari Terada, Wataru Sugiura, et al. (+2)
112 [GO] 2022―Dec―06 Clinical outcomes of COVID-19 caused by the Alpha variant compared with one by wild type in Kobe, Japan. A multi-center nested case-control study Asako Doi, Kentaro Iwata, Tadahiro Nakamura, Koji Oh, Kenichi Isome, Kohei Hasegawa, et al. (+12)
113 [GO] 2022―Dec―05 Nosocomial transmission of SARS-CoV-2 from infected children to uninfected caregivers: A retrospective cohort study in a Japanese tertiary children's hospital Akihiko Shimizu, Sachiko Kitazume
114 [GO] 2022―Nov―26 Humoral response and safety of the BNT162b2 and mRNA-1273 COVID-19 vaccines in allogeneic hematopoietic stem cell transplant recipients: An observational study Masashi Nishikubo, Yoshimitsu Shimomura, Hayato Maruoka, Seiko Nasu, Tomomi Nishioka, Kenji Sakizono, et al. (+15)
115 [GO] 2022―Nov―25 Comparison of methylprednisolone pulse vs conventional dexamethasone for adult cases of COVID-19 requiring oxygen; a Japanese retrospective cohort study Yusuke Watanabe, Itaru Nakamura, Satoko Sato, Hiroaki Fujita, Takehito Kobayashi, Hidehiro Watanabe
116 [GO] 2022―Nov―20 Analytical performance of the rapid qualitative antigen kit for the detection of SARS-CoV-2 during widespread circulation of the Omicron variant Hiromichi Suzuki, Yusaku Akashi, Daisuke Kato, Yuto Takeuchi, Yoshihiko Kiyasu, Norihiko Terada, et al. (+6)
117 [GO] 2022―Nov―19 Increasing cardiac troponin-I level as a cardiac injury index correlates with in-hospital mortality and biofactors in severe hospitalised COVID-19 patients Reza Javidi Dasht Bayaz, Vahid Reza Askari, Mohammad Tayyebi, Mostafa Ahmadi, Alireza Heidari-Bakavoli, Vafa Baradaran Rahimi
118 [GO] 2022―Nov―13 Successful treatment of proven coronavirus disease 2019-associated pulmonary aspergillosis with liposomal amphotericin B in a patient with bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation Yosuke Nakaya, Yasuhiro Nakashima, Naonori Harada, Koichi Yamada, Yosuke Makuuchi, Masatomo Kuno, et al. (+12)
119 [GO] 2022―Nov―13 Clinical characteristics of patients with coronavirus disease 2019-associated pulmonary aspergillosis on mechanical ventilation: A single-center retrospective study in Japan Yoshihiko Ogawa, Kenya Murata, Kohei Hasegawa, Koji Nishida, Iwao Gohma, Kei Kasahara
120 [GO] 2022―Oct―26 Favipiravir for symptomatic COVID-19: A nationwide observational cohort study Yohei Doi, Takuma Ishihara, Sumi Banno, Masahiko Ando, Masashi Kondo
121 [GO] 2022―Oct―23 Analysis of diagnostic performance and factors causing nonspecific reactions in SARS-CoV-2 rapid antigen detection tests Natsuki Narumi, Takashi Kondoh, Yuki Sato, Yuki Katayama, Shinya Nirasawa, Masachika Saeki, et al. (+4)
122 [GO] 2022―Oct―17 Analytical sensitivity of six lateral flow antigen test kits for variant strains of SARS-CoV-2 Yoshitomo Morinaga, Hiroshi Yamada, Yoshihiro Yoshida, Hitoshi Kawasuji, Yoshihiro Yamamoto
123 [GO] 2022―Oct―12 Evaluation of physical and psychological status of health care workers infected with COVID-19 during a hospital outbreak in Japan Koji Kameyama, Kosuke Mizutani, Yukiko Miyake, Toma Iwase, Yoshio Mizutani, Mikito Yamada, et al. (+3)
124 [GO] 2022―Sep―30 Diagnostic test property of transcription-reverse transcription concerted reaction reagent TRCReady® SARS-CoV-2 i using nasopharyngeal swab samples Megumi Ogawa, Manami Sato, Asuka Yamakami, Yuki Hayasaka, Yoshiko Saya, Kurando Une, et al. (+5)
125 [GO] 2022―Sep―25 Patients with B-cell malignancies experience reduced antibody responses with class switching defect following BNT162b2 SARS-CoV-2 vaccination Yu Nakagama, Sung-Gi Chi, Yosuke Minami, Reiko Watanabe, Michiteru Yamagishi, Uno Atsuko, Yasutoshi Kido
126 [GO] 2022―Sep―21 Safety of and antibody response to the BNT162b2 COVID-19 vaccine in adolescents and young adults with underlying disease Kensuke Shoji, Takanori Funaki, Masaki Yamada, Masashi Mikami, Kozue Miyake, Saki Ueno, et al. (+7)
127 [GO] 2022―Sep―16 Effect of the COVID-19 Pandemic and State of Emergency Declarations on the Relative Incidence of Legionellosis and Invasive Pneumococcal Disease in Japan Cyrus Ghaznavi, Masahiro Ishikane, Daisuke Yoneoka, Yuta Tanoue, Takayuki Kawashima, Akifumi Eguchi, Shuhei Nomura
128 [GO] 2022―Sep―14 Temporal trends in microbial detection during the COVID-19 pandemic: analysis of the Japan Surveillance for Infection Prevention and Healthcare Epidemiology (J-SIPHE) database Akira Endo, Yusuke Asai, Taichi Tajima, Mio Endo, Takayuki Akiyama, Nobuaki Matsunaga, et al. (+3)
129 [GO] 2022―Sep―13 Incidence of acute exacerbation in patients with interstitial lung disease after COVID-19 vaccination Masashi Sakayori, Eri Hagiwara, Tomohisa Baba, Hideya Kitamura, Akimasa Sekine, Satoshi Ikeda, et al. (+4)
130 [GO] 2022―Sep―13 Short-course remdesivir for healthcare-associated COVID-19: case series from a non-acute care hospital Yu Takahashi, Hideaki Wakita, Takuma Ishihara, Hideto Okazaki, Akihiro Ito, Mitsunaga Iwata, et al. (+2)
131 [GO] 2022―Sep―11 Comparison of clinical characteristics of COVID-19 in pregnant women between the Delta and Omicron variants of concern predominant periods Kensuke Shoji, Shinya Tsuzuki, Takayuki Akiyama, Nobuaki Matsunaga, Yusuke Asai, Setsuko Suzuki, et al. (+7)
132 [GO] 2022―Sep―11 The burden of viral infections in pediatric intensive care unit between endemic and pandemic coronavirus infections: A tertiary care center experience Ayman Al-Eyadhy, Mohammed Almazyad, Gamal Hasan, Qais Almuhaideb, Nasser AbuDujain, Ali A.N. Alhaboob, et al. (+7)
133 [GO] 2022―Sep―08 An early return-to-work program for COVID-19 close contacts in healthcare during the Omicron wave in Japan Hiroyuki Naruse, Yohei Doi, Mitsunaga Iwata, Kiyohito Ishikawa
134 [GO] 2022―Sep―08 Potential usage of anterior nasal sampling in clinical practice with three rapid antigen tests for SARS-CoV-2 Hidetoshi Nomoto, Kei Yamamoto, Erina Isaka, Yusuke Miyazato, Tetsuya Suzuki, Taketomo Maruki, et al. (+11)
135 [GO] 2022―Sep―05 Antibody titers and neutralizing activity in cases of COVID-19 after a single dose of vaccination Nobumasa Okumura, Sho Saito, Yuki Takamatsu, Junko S. Takeuchi, Yusuke Asai, Mio Sanada, et al. (+4)
136 [GO] 2022―Sep―03 The impact of the COVID-19 pandemic on other infections differs by their route of transmission: A retrospective, observational study in Japan Akira Komori, Hirotake Mori, Toshio Naito
137 [GO] 2022―Aug―31 Clinical Effect of Early administration of Tocilizumab Following the Initiation of Corticosteroid Therapy for Patients with COVID-19 Takaya Kawamata (, Yoshinori Tanino (, Takefumi Nikaido (, Hiroyuki Minemura (, Yuki Sato (, Ryuichi Togawa (, et al. (+13)
138 [GO] 2022―Aug―23 Can Torque teno virus be a predictor of SARS-CoV-2 disease progression in cancer patients? Vanessa Emmel, Bianca Gama, Alessandra de Paula, Gerson Ferreira, Renata Binato, Eliana Abdelhay
139 [GO] 2022―Aug―19 Lessons learned from an outbreak of COVID-19 in the head and neck surgery ward of a Japanese cancer center during the sixth wave by Omicron Naoya Itoh, Nana Akazawa, Masahiro Ishikane, Takanori Kawabata, Daichi Kawamura, Tomoyuki Chikusa, et al. (+2)
140 [GO] 2022―Aug―19 Factors related to the serious adverse events in patients visiting the emergency department after ChAdOx1 and mRNA COVID-19 vaccination Won Jung Jeong, Byung Hak So, Hyung Min Kim, Kyungman Cha, Woon Jeong Lee, Sikyoung Jeong, et al. (+2)
141 [GO] 2022―Aug―11 Post COVID-19 condition of the Omicron variant of SARS-CoV-2 S. Morioka, S. Tsuzuki, M. Suzuki, M. Terada, M. Akashi, Y. Osanai, et al. (+10)
142 [GO] 2022―Aug―10 Clinical characteristics of COVID-19 in hospitalized children during the Omicron variant predominant period Kensuke Shoji, Takayuki Akiyama, Shinya Tsuzuki, Nobuaki Matsunaga, Yusuke Asai, Setsuko Suzuki, et al. (+3)
143 [GO] 2022―Aug―09 Viral load may impact the diagnostic performance of nasal swabs in nucleic acid amplification test and quantitative antigen test for SARS-CoV-2 detection Yoshihiro Fujiya, Yuki Sato, Yuki Katayama, Shinya Nirasawa, Mikako Moriai, Masachika Saeki, et al. (+5)
144 [GO] 2022―Aug―09 Inferring the true number of SARS-CoV-2 infections in Japan Lauren McKenzie, Affan Shoukat, Kai On Wong, Koju Itahashi, Eiji Yasuda, Alex Demarsh, Kamran Khan
145 [GO] 2022―Aug―06 A comparative analysis of the outcomes of patients with influenza or COVID-19 in a tertiary hospital in Belgium Silvio Wallemacq, Celestin Danwang, Anais Scohy, Leila Belkhir, Julien De Greef, Benoit Kabamba, Jean Cyr Yombi
146 [GO] 2022―Aug―04 Clinical characteristics of pediatric patients with COVID-19 between Omicron era vs. pre-Omicron era Hiroyuki Iijima, Mitsuru Kubota, Chikara Ogimi
147 [GO] 2022―Jul―31 Immunological responses following the third dose of the BNT162b2 SARS-CoV-2 vaccine among Japanese healthcare workers Miku Tamura, Retsu Fujita, Tomoaki Sato, Ryohei Sato, Yasuyuki Kato, Mitsuaki Nagasawa, Tetsuya Matsumoto
148 [GO] 2022―Jul―20 Antibody responses and SARS-CoV-2 infection after BNT162b2 mRNA booster vaccination among healthcare workers in Japan Hidetoshi Igari, Haruna Asano, Shota Murata, Toshihiko Yoshida, Kenji Kawasaki, Takahiro Kageyama, et al. (+11)
149 [GO] 2022―Jul―19 Candida dubliniensis fungemia in a patient with severe COVID-19: A case report Ayaka Kakehi, Hideharu Hagiya, Koji Iio, Yasuhiro Nakano, Hiromi Ihoriya, Yuki Taira, et al. (+4)
150 [GO] 2022―Jul―19 Concurrent coronavirus disease 2019 and primary syphilis in a young man: A rare case report Yoshihiro Kitahara, Rie Nakamura, Mafumi Okimoto, Kei Miwata, Noriaki Ito, Toshiro Takafuta
151 [GO] 2022―Jul―08 Timing of REGEN-COV administration and progression to severe COVID-19 Tomoka Kadowaki, Sato Imajou, Naomi Matsumoto, Soshi Takao, Takashi Yorifuji
152 [GO] 2022―Jul―08 Usefulness of the Legionella Score for differentiating from COVID-19 pneumonia to Legionella pneumonia Naoyuki Miyashita, Futoshi Higa, Yosuke Aoki, Toshiaki Kikuchi, Masafumi Seki, Kazuhiro Tateda, et al. (+4)
153 [GO] 2022―Jun―29 Temporal trends in clinical characteristics and in-hospital mortality among patients with COVID-19 in Japan for waves 1, 2, and 3: A retrospective cohort study Hideki Endo, Kyunghee Lee, Tetsu Ohnuma, Senri Watanabe, Kiyohide Fushimi
154 [GO] 2022―Jun―20 Risk factors for disease severity and mortality of children with Covid-19: A study at a Vietnamese Children's hospital Phung Nguyen Nguyen-The, Tran Thuc Thanh, Nguyen Hung Thanh, Le Thinh Quoc, Ngo Minh Ngoc-Quang, Dang Duy Quoc, et al. (+5)
155 [GO] 2022―Jun―16 Changes in diagnostic usefulness of the JRS scoring system in COVID-19 pneumonia by SARS-CoV-2 vaccination Naoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, Naoki Fukuda, Akihisa Yamura, Yoshihisa Ishiura, Shosaku Nomura
156 [GO] 2022―Jun―13 Predictors of silent hypoxia in hospitalized patients with COVID-19 in Japan Kayoko Hayakawa, Shinichiro Morioka, Yusuke Asai, Shinya Tsuzuki, Gen Yamada, Setsuko Suzuki, et al. (+2)
157 [GO] 2022―Jun―13 Risk factors associated with hospitalization in patients with asymptomatic or mild COVID-19 in public accommodation facilities in Tokyo Yohei Sakamoto, Kenichi Satoh, Takuma Tanaka, Takayuki Yamaguchi, Tomomi Miyamoto, Kenji Sawaki, et al. (+7)
158 [GO] 2022―Jun―06 Factors affecting the serologic response to SARS-CoV-2 vaccination in patients with solid tumors: A prospective study Atike Pınar Erdoğan, Ferhat Ekinci, Sinem Akçali, Gamze Göksel
159 [GO] 2022―Jun―01 Emerging norovirus GII.4 Sydney[P31] causing acute gastroenteritis outbreak in children in Japan, during COVID-19, 2021 Ngan Thi Kim Pham, Shuichi Nishimura, Yuko Shimizu-Onda, Quang Duy Trinh, Shihoko Komine-Aizawa, Pattara Khamrin, et al. (+6)
160 [GO] 2022―May―26 Clinical efficacy of casirivimab-imdevimab antibody combination treatment in patients with COVID-19 Delta variant Naoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, Naoki Fukuda, Akihisa Yamura, Yoshihisa Ishiura
161 [GO] 2022―May―23 A case of Bacillus subtilis var. natto bacteremia caused by ingestion of natto during COVID-19 treatment in a maintenance hemodialysis patient with multiple myeloma Ai Kato, Ayumi Yoshifuji, Kohji Komori, Kotaro Aoki, Daisuke Taniyama, Motoaki Komatsu, et al. (+5)
162 [GO] 2022―May―17 Efficacy and safety of mRNA SARS-CoV-2 vaccines in lung transplant recipients Takashi Hirama, Miki Akiba, Yuki Shundo, Tatsuaki Watanabe, Yui Watanabe, Hisashi Oishi, et al. (+2)
163 [GO] 2022―May―11 Adverse events after BNT162b2 mRNA COVID-19 vaccination in health care workers and medical students in Japan Takahiro Namiki, Shihoko Komine-Aizawa, Kazuhide Takada, Chika Takano, Quang Duy Trinh, Satoshi Hayakawa
164 [GO] 2022―May―11 A case of severe COVID-19 with pulmonary thromboembolism related to heparin-induced thrombocytopenia during prophylactic anticoagulation therapy Kosaku Sasaki, Masayuki Murata, Keiji Nakamura, Yuji Matsumoto, Yuko Nakashima, Sho Yamasaki, et al. (+7)
165 [GO] 2022―May―02 Analysis of older adults visiting the emergency department with fever as a suspected Covid-19 vaccine-related adverse reaction: A retrospective multicenter study Sikyoung Jeong, Sungyoup Hong, Taehoon Oh, Seon Hee Woo, Woon Jeong Lee, Daehee Kim, Won Jung Jeong
166 [GO] 2022―Apr―22 Neutralising activity and antibody titre in 10 patients with breakthrough infections of the SARS-CoV-2 Omicron variant in Japan Nobumasa Okumura, Shinya Tsuzuki, Sho Saito, Shin-ichiro Hattori, Junko S. Takeuchi, Tomoya Saito, et al. (+6)
167 [GO] 2022―Apr―14 Beneficial ex vivo immunomodulatory and clinical effects of clarithromycin in COVID-19 Timothy Arthur Chandos Snow, Alessia Longobardo, David Brealey, Jim Down, Giovanni Satta, Mervyn Singer, Nishkantha Arulkumaran
168 [GO] 2022―Apr―13 Epidemiology of SARS-CoV-2 infection in nursing facilities and the impact of their clusters in a Japanese core city Koki Shimizu, Haruka Maeda, Eiichiro Sando, Ayumi Fujita, Masato Tashiro, Takeshi Tanaka, et al. (+3)
169 [GO] 2022―Apr―11 Outcome of COVID-19 in interstitial lung disease patients treated with anti-inflammatory drugs and antiviral drugs Takafumi Yamaya, Eri Hagiwara, Tomohisa Baba, Tae Iwasawa, Takashi Ogura
170 [GO] 2022―Apr―11 TAFRO syndrome with a fatal clinical course following BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccination: A case report Maaya Yamada, Ryuichi Minoda Sada, Eriko Kashihara, Gosuke Okubo, Sho Matsushita, Atsushi Manabe, et al. (+4)
171 [GO] 2022―Apr―07 Three SARS-CoV-2 PCR-negative cases of COVID-19 diagnosed using isothermal amplification methods Saeko Shinozawa, Yuki Moriyama
172 [GO] 2022―Apr―07 Prolonged shedding of infectious viruses with haplotype switches of SARS-CoV-2 in an immunocompromised patient Kosuke Shoji, Akira Suzuki, Michiko Okamoto, Emmanuel Kagning Tsinda, Naoko Sugawara, Mie Sasaki, et al. (+4)
173 [GO] 2022―Apr―07 REGN-COV2 antibody cocktail in patients with SARS-CoV-2: Observational study from a single institution in Japan Ayana Sakurai, Shoko Marshall, Tomoko Ogasawara, Toshie Ogasawara, Yoshikazu Aoka, Hiroshi Sakura, et al. (+2)
174 [GO] 2022―Apr―01 Anti-spike protein antibody titer at the time of breakthrough infection of SARS-CoV-2 omicron Eisuke Adachi, Etsuko Nagai, Makoto Saito, Masamichi Isobe, Takaaki Konuma, Michiko Koga, et al. (+3)
175 [GO] 2022―Mar―28 Case of a pregnant woman with probable prolonged SARS-CoV-2 viral shedding 221 days after diagnosis Dai Akine, Teppei Sasahara, Ayako Koido, Kaori Abe, Kanako Abe, Akinori Oki, et al. (+2)
176 [GO] 2022―Mar―25 Adverse reactions to the first and second doses of Pfizer-BioNTech COVID-19 vaccine among healthcare workers Ayano Maruyama, Teiji Sawa, Satoshi Teramukai, Norito Kato
177 [GO] 2022―Mar―25 Does the timing of saliva collection affect the diagnosis of SARS-CoV-2 infection? Yuki Katayama, Ryosei Murai, Mikako Moriai, Shinya Nirasawa, Masachika Saeki, Yuki Yakuwa, et al. (+5)
178 [GO] 2022―Mar―23 Successful use of casirivimab/imdevimab anti-spike monoclonal antibodies to enhance neutralizing antibodies in a woman on anti-CD20 treatment with refractory COVID-19 Yusuke Miyazato, Kei Yamamoto, Yuichiro Nakaya, Shinichiro Morioka, Junko S. Takeuchi, Yuki Takamatsu, et al. (+6)
179 [GO] 2022―Mar―23 Disparities in co-payments for influenza vaccine among the elderly, during the COVID-19 pandemic in Japan Takayuki Ando, Tomoki Maruyama, Aki Tamai, Taro Murakami, Yasuaki Kido, Toru Ishida, et al. (+4)
180 [GO] 2022―Mar―22 Duration of infectious viral shedding in patients with mild to moderate COVID-19 treated with REGN-CoV2 Toshihito Nomura, Hiroki Kitagawa, Masaki Kakimoto, Yuki Kaiki, Tanuza Nazmul, Daisuke Miyamori, et al. (+5)
181 [GO] 2022―Mar―21 Maoto, a traditional herbal medicine, for post-exposure prophylaxis for Japanese healthcare workers exposed to COVID-19: A single center study Atsuko Nabeshima, Atsuhiko Sakamoto, Kaoru Iwata, Yuji Kitamura, Shinta Masui, Shinjiro Inomata, et al. (+3)
182 [GO] 2022―Mar―19 Clinical features of nursing and healthcare-associated pneumonia due to COVID-19 Naoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, Naoki Fukuda, Akihisa Yamura, Yoshihisa Ishiura, Shosaku Nomura
183 [GO] 2022―Mar―18 Delayed dexamethasone treatment at initiation of oxygen supplementation for coronavirus disease 2019 is associated with the exacerbation of clinical condition Yuta Ibe, Tomoyuki Ishigo, Satoshi Fujii, Yoshihiro Fujiya, Koji Kuronuma, Takeshi Tsugawa, et al. (+2)
184 [GO] 2022―Mar―15 Epidemiological and clinical characteristics of infections with seasonal human coronavirus and respiratory syncytial virus in hospitalized children immediately before the coronavirus disease 2019 pandemic Yohei Kume, Koichi Hashimoto, Kazuya Shirato, Sakurako Norito, Reiko Suwa, Mina Chishiki, et al. (+10)
185 [GO] 2022―Mar―14 Triaging of COVID-19 patients using low dose chest CT: Incidence and factor analysis of lung involvement on CT images Wataru Fukumoto, Yuko Nakamura, Kenichi Yoshimura, Takahiro Sueoka, Fuminari Tatsugami, Naoyuki Kitamura, et al. (+2)
186 [GO] 2022―Mar―08 Dynamics of anti-Spike IgG antibody level after the second BNT162b2 COVID-19 vaccination in health care workers Hiroaki Ikezaki, Hideyuki Nomura, Nobuyuki Shimono
187 [GO] 2022―Mar―07 Vaginal delivery after improvement in COVID-19 by monoclonal antibody treatment: A case report and literature review Eisuke Ogawa, Hirohisa Goto, Hiroyasu Ushimaru, Akemi Matsuo, Satoshi Takeda, Ryohei Nishimura, et al. (+2)
188 [GO] 2022―Mar―01 Adverse effect investigation using application software after vaccination against SARS-CoV-2 for healthcare workers Shingo Yamazaki, Kenta Watanabe, Yoshio Okuda, Misao Urushihara, Hiromi Koshikawa, Hitoshi Chiba, et al. (+6)
189 [GO] 2022―Feb―24 Can naive Bayes classifier predict infection in a close contact of COVID-19? A comparative test for predictability of the predictive model and healthcare workers in Japan Hideo Yoshikawa
190 [GO] 2022―Feb―24 A prospective clinical evaluation of the diagnostic accuracy of the SARS-CoV-2 Rapid Antigen Test using anterior nasal samples Yusaku Akashi, Michiko Horie, Yuto Takeuchi, Kenichi Togashi, Yuki Adachi, Atsuo Ueda, et al. (+6)
191 [GO] 2022―Feb―17 A case of encephalitis following COVID-19 vaccine Yuya Kobayashi, Seishu Karasawa, Nobuhiko Ohashi, Kanji Yamamoto
192 [GO] 2022―Feb―11 A case report of breakthrough infection with the SARS-CoV-2 delta variant and household transmission: Role of vaccination, anti-spike IgG and neutralizing activity Yuki Moriyama, Masahiro Ishikane, Mikako Ueno, Akihiro Matsunaga, Yukihito Ishizaka, Takeshi Arashiro, et al. (+3)
193 [GO] 2022―Feb―10 Prolonged SARS-CoV-2 infection associated with long-term corticosteroid use in a patient with impaired B-cell immunity Momoko Morishita, Manabu Suzuki, Akihiro Matsunaga, Keishi Ishizhima, Tsukasa Yamamoto, Yudai Kuroda, et al. (+14)
194 [GO] 2022―Feb―10 Early identification of novel coronavirus (COVID-19) pneumonia using clinical and radiographic findings Naoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, Naoki Fukuda, Akihisa Yamura, Yoshihisa Ishiura, Shosaku Nomura
195 [GO] 2022―Feb―09 Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 pPanel, a rRapid mMultiplex PCR mMethod for the dDiagnosis of COVID-19 Masahiro Ishikane, Hiroyuki Unoki-Kubota, Ataru Moriya, Satoshi Kutsuna, Honami Ando, Yasushi Kaburagi, et al. (+4)
196 [GO] 2022―Feb―09 Intensive care burden of COVID-19 in tertiary care hospitals during the first year of outbreak in Kawasaki City, Japan: A retrospective cohort study Tomohiro Hosoda, Shota Hamada, Kenji Numata, Yutaka Saito, Satsuki Yamazaki, Ayu Minoura, et al. (+2)
197 [GO] 2022―Feb―09 Investigation of the incidence of immunisation stress-related response following COVID-19 vaccination in healthcare workers Tomonori Takano, Masanori Hirose, Yukitaka Yamasaki, Masatoshi Hara, Tomoyuki Okada, Hiroyuki Kunishima
198 [GO] 2022―Feb―01 A SARS-CoV-2 Delta vVariant cContaining mMutation in the pProbe bBinding rRegion uUsed for RT-qPCR tTest in Japan eExhibited aAtypical PCR aAmplification and mMight iInduce fFalse nNegative rResult Samiul Alam Rajib, Yasuhiro Ogi, Md Belal Hossain, Terumasa Ikeda, Eiichi Tanaka, Tatsuya Kawaguchi, Yorifumi Satou
199 [GO] 2022―Jan―31 Persistent viral shedding of severe acute respiratory syndrome coronavirus 2 after treatment with bendamustine and rituximab: A case report Tatsuya Arai, Satoru Mukai, Ryo Kazama, Yoshihiko Ogawa, Koji Nishida, Kazuo Hatanaka, Iwao Gohma
200 [GO] 2022―Jan―26 Impact of coronavirus disease 2019 on infectious disease treatment and infection control at a tertiary hospital in Japan Waki Imoto, Koichi Yamada, Gaku Kuwabara, Wataru Shibata, Norihiro Sakurai, Yuka Nonose, et al. (+4)
201 [GO] 2022―Jan―24 Infliximab treatment for refractory COVID-19-associated multisystem inflammatory syndrome in a Japanese child Yohei Yamaguchi, Kei Takasawa, Hitoshi Irabu, Kanako Hiratoko, Yosuke Ichigi, Ko Hirata, et al. (+10)
202 [GO] 2022―Jan―21 Decreased number of inpatients with community-acquired pneumonia during the COVID-19 pandemic: A large multicenter study in Japan Yan Yan, Kiyohide Tomooka, Toshio Naito, Takeshi Tanigawa
203 [GO] 2022―Jan―20 Comparison of the clinical characteristics and outcomes of COVID-19 in children before and after the emergence of Delta variant of concern in Japan Kensuke Shoji, Takayuki Akiyama, Shinya Tsuzuki, Nobuaki Matsunaga, Yusuke Asai, Setsuko Suzuki, et al. (+3)
204 [GO] 2022―Jan―11 Adverse reactions to the BNT162b2 and mRNA-1273 mRNA COVID-19 vaccines in Japan Hiroki Kitagawa, Yuki Kaiki, Aya Sugiyama, Shintaro Nagashima, Akemi Kurisu, Toshihito Nomura, et al. (+5)
205 [GO] 2022―Jan―06 Clinical features and outcomes of coronavirus disease 2019 in early infants in Japan: A case series and literature review Hiroyuki Iijima, Takanori Funaki, Mitsuru Kubota
206 [GO] 2022―Jan―05 Impact of regional heterogeneity on the severity of COVID-19 Shinya Tsuzuki, Yusuke Asai, Nobuaki Matsunaga, Haruhiko Ishioka, Takayuki Akiyama, Norio Ohmagari
207 [GO] 2022―Jan―03 Surgically treated reactive arthritis of the ankle after COVID-19 infection: A case report Kohei Shimoyama, Atsushi Teramoto, Yasutaka Murahashi, Katsunori Takahashi, Kota Watanabe, Kousuke Iba, Toshihiko Yamashita
208 [GO] 2021―Dec―31 Ivermectin administration is associated with lower gastrointestinal complications and greater ventilator-free days in ventilated patients with COVID-19: A propensity score analysis Kentaro Shimizu, Haruhiko Hirata, Daijiro Kabata, Natsuko Tokuhira, Moe Koide, Akiko Ueda, et al. (+5)
209 [GO] 2021―Dec―31 Clinical eEvaluation of the rRapid nNucleic aAcid aAmplification pPoint-of-cCare tTest (Smart Gene SARS-CoV-2) in the aAnalysis of nNasopharyngeal and aAnterior nNasal samples. Yoshihiko Kiyasu, Masato Owaku, Yusaku Akashi, Yuto Takeuchi, Kenji Narahara, Sunao Mori, et al. (+6)
210 [GO] 2021―Dec―30 Safety and Immunogenicity of the COVID-19 vaccine BNT162b2 in patients undergoing chemotherapy for solid cancer Yohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, Wataru Hojo, Hironori Sakai, Ryo Takai, et al. (+12)
211 [GO] 2021―Dec―30 Antibody responses induced by the BNT162b2 mRNA COVID-19 vaccine in healthcare workers in a single community hospital in Japan Shinya Otsuka, Kei Hiraoka, Masato Suzuoki, Hideki Ujiie, Tatsuya Kato, Isao Yokota, et al. (+5)
212 [GO] 2021―Dec―15 A warning related to predicting the severity of COVID-19 pneumonia using the A-DROP scoring system Naoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, Naoki Fukuda, Akihisa Yamura, Yoshihisa Ishiura, Shosaku Nomura
213 [GO] 2021―Dec―07 Interpretations of SARS-CoV-2 IgM and IgG antibody titers in the seroepidemiological study of asymptomatic healthy volunteers Akihisa Mitani, Takeshi Horie, Rin Yokoyama, Yuki Nakano, Kensuke Hamada, Yukiko Inoue, et al. (+15)
214 [GO] 2021―Nov―30 Effectiveness of monoclonal antibody therapy for COVID-19 patients using a risk scoring system Yoshikazu Mutoh, Takumi Umemura, Aiko Ota, Keisuke Okuda, Ryoma Moriya, Mayumi Tago, et al. (+16)
215 [GO] 2021―Nov―29 Antibody titers against the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2 induced by BNT162b2 vaccination measured using automated chemiluminescent enzyme immunoassay Hideaki Kato, Kei Miyakawa, Norihisa Ohtake, Hirofumi Go, Yutaro Yamaoka, Satoshi Yajima, et al. (+4)
216 [GO] 2021―Nov―25 Recovery from severe persistent COVID-19 without evidence of an anti-SARS-CoV-2 antibody response in a man with mantle cell lymphoma treated with rituximab Hiroshi Horiuchi, Hiroaki Sasaki, Kazuhito Miyazaki, Nobuyuki Miyata, Yukihiro Yoshimura, Natsuo Tachikawa
217 [GO] 2021―Nov―17 Omental infarction in mild Covid-19 infection Abdurrahman Kaya, Sibel Yıldız Kaya, Hakan Baydar, Işıl Bavunoğlu
218 [GO] 2021―Nov―17 The effect of higher-intensity-dosing anticoagulation in the clinical outcomes in hospitalized patients with COVID-19: A meta-analysis of randomized controlled trials Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
219 [GO] 2021―Nov―13 Stability of SARS-CoV-2 and influenza virus varies across different paper types Ryohei Hirose, Hajime Miyazaki, Risa Bandou, Naoto Watanabe, Takuma Yoshida, Tomo Daidoji, et al. (+2)
220 [GO] 2021―Nov―12 Potential for false-positive results with quantitative antigen tests for SARS-CoV-2: A case of a child with acute respiratory infection Ryota Hase, Takashi Kurita, Haruki Mito, Yudai Yano, Tomohisa Watari, Yoshihito Otsuka, et al. (+2)
221 [GO] 2021―Nov―10 Viral isolation analysis of SARS-CoV-2 from clinical specimens of COVID-19 patients Emiko Igarashi, Hideki Tani, Kosuke Tamura, Masae Itamochi, Takahisa Shimada, Yumiko Saga, et al. (+16)
222 [GO] 2021―Nov―10 Evaluation and clinical implications of the time to a positive results of antigen testing for SARS-CoV-2 Yusaku Akashi, Yoshihiko Kiyasu, Yuto Takeuchi, Daisuke Kato, Miwa Kuwahara, Shino Muramatsu, et al. (+5)
223 [GO] 2021―Nov―10 A study of quality assessment in SARS-CoV-2 pathogen nucleic acid amplification tests performance; from the results of external quality assessment survey of clinical laboratories in the Tokyo Metropolitan Government external quality assessment program in 2020 Yoshikazu Ishii, Kotaro Aoki, Mayuko Oda, Megumi Ichikawa, Rie Moriuchi, Hiroyuki Konishi, et al. (+3)
224 [GO] 2021―Nov―09 Indications for SARS-CoV-2 nucleic acid amplification test for areas with low endemicity Hisao Higo, Yoshinori Taguchi, Noriyuki Suzaki, Takuya Nagata, Masaomi Marukawa
225 [GO] 2021―Oct―30 Corrigendum to ’ Time-course evaluation of the quantitative antigen test for severe acute respiratory syndrome coronavirus 2: The potential contribution to alleviating isolation of COVID-19 patients’[27 (2021) 1669-1673] Hidetoshi Nomoto, K. Yamamoto
226 [GO] 2021―Oct―28 Clinical Characteristics and Prognosis of Immunosuppressed Inpatients with COVID-19 in Japan Hidetoshi Nomoto, Setsuko Suzuki, Yusuke Asai, Kayoko Hayakawa, Hiroyuki Gatanaga, Mari Terada, et al. (+4)
227 [GO] 2021―Oct―27 Diagnostic performance of a novel digital immunoassay (RapidTesta SARS-CoV-2): A prospective observational study with nasopharyngeal samples Hiromichi Suzuki, Yusaku Akashi, Atsuo Ueda, Yoshihiko Kiyasu, Yuto Takeuchi, Yuta Maehara, et al. (+5)
228 [GO] 2021―Oct―25 Pure red cell aplasia accompanied by COVID-19 successfully treated using cyclosporine Susumu Yamazaki, Erika Naito, Ryu Sekiya, Sanehiro Yogi, Kenichiro Komiyama, Yoshitaka Miyakawa, Makoto Nagata
229 [GO] 2021―Oct―22 A fatal case of extensive gastrointestinal necrosis due to portal and mesenteric vein thrombosis in the post-acute phase of COVID-19 Tomohiro Hosoda, Hideki Orikasa
230 [GO] 2021―Oct―22 Fatty Liver on Computed Tomography Scan on Admission is a Risk Factor for Severe Coronavirus Disease Ayako Okuhama, Masatoshi Hotta, Masahiro Ishikane, Akira Kawashima, Yusuke Miyazato, Mari Terada, et al. (+27)
231 [GO] 2021―Oct―22 Factors associated with high antibody titer following coronavirus disease among 581 convalescent plasma donors: A single-center cross-sectional study in Japan Tetsuya Suzuki, Yusuke Asai, Satoshi Ide, Saori Fukuda, Akihito Tanaka, Yumiko Shimanishi, et al. (+17)
232 [GO] 2021―Oct―20 Elevated blood favipiravir levels are inversely associated with ferritin levels and induce the elevation of uric acid levels in COVID-19 treatment: A retrospective single-center study Go Morikawa, Ken Kubota, Daichi Kondo, Yasuhisa Takanashi, Satoshi Minami, Tsunemichi Kinjo, et al. (+4)
233 [GO] 2021―Oct―02 Evaluation of minocycline combined with favipiravir therapy in coronavirus disease 2019 patients: a case-series study Kazuhiro Itoh, Ippei Sakamaki, Tomoya Hirota, Hiromichi Iwasaki
234 [GO] 2021―Oct―02 Multisystem inflammatory syndrome in adults after acute coronavirus disease 2019 in a Japanese woman: A case report Kyohei Miyamoto, Yusuke Koizumi, Shinobu Tamura, Tsuyoshi Nakashima, Kaori Kobai, Rikako Tanaka, et al. (+5)
235 [GO] 2021―Sep―21 Comparative study of SmartAmp assay and reverse transcription-polymerase chain reaction by saliva specimen for the diagnosing COVID-19 Nobuhiro Asai, Akiko Nakamura, Daisuke Sakanashi, Isao Koita, Wataru Ohashi, Yuzuka Kawamoto, et al. (+11)
236 [GO] 2021―Sep―20 COVID-19 vaccine induced interstitial lung disease Ayumi Yoshifuji, Kota Ishioka, Yuya Masuzawa, Shuntaro Suda, Saori Murata, Yoshifumi Uwamino, et al. (+6)
237 [GO] 2021―Sep―16 Reactogenicity following two doses of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers in Japan Mizue Saita, Yan Yan, Kanami Ito, Hiroshi Sasano, Kuniaki Seyama, Toshio Naito
238 [GO] 2021―Sep―10 Duration of infectious virus shedding in patients with severe coronavirus disease 2019 who required mechanical ventilation Toshihito Nomura, Hiroki Kitagawa, Keitaro Omori, Norifumi Shigemoto, Masaki Kakimoto, Tanuza Nazmul, et al. (+3)
239 [GO] 2021―Aug―25 Risk factors in pediatric hospitalization for influenza A and B during the seven seasons immediately before the COVID-19 era in Japan Masayoshi Shinjoh, Munehiro Furuichi, Atsushi Narabayashi, Akinobu Kamei, Naoko Yoshida, Takao Takahashi
240 [GO] 2021―Aug―25 Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): a single-centre randomized, placebo-controlled trial Anant Mohan, Pawan Tiwari, Tejas Menon Suri, Saurabh Mittal, Ankit Patel, Avinash Jain, et al. (+21)
241 [GO] 2021―Aug―16 Does the E gene provide additional information in SARS-CoV-2 PCR? András Zóka, Gabriella Bekő
242 [GO] 2021―Aug―14 Time-course evaluation of the quantitative antigen test for severe acute respiratory syndrome coronavirus 2: the potential contribution to alleviating isolation of COVID-19 patients Hidetoshi Nomoto, Kei Yamamoto, Gen Yamada, Michiyo Suzuki, Noriko Kinoshita, Jin Takasaki, et al. (+4)
243 [GO] 2021―Aug―13 The usefulness of a combination of age, body mass index, and blood urea nitrogen as prognostic factors in predicting oxygen requirements in patients with coronavirus disease 2019 Goto Norihiko, Yosuke Wada, Yuichi Ikuyama, Jumpei Akahane, Makoto Kosaka, Atsuhito Ushiki, et al. (+8)
244 [GO] 2021―Aug―12 Coronavirus disease (COVID-19) associated delayed-onset fulminant myocarditis in patient with a history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection Hiroyasu Ishikura, Junichi Maruyama, Kota Hoshino, Yuta Matsuoka, Masaya Yano, Tadaaki Arimura, et al. (+4)
245 [GO] 2021―Aug―12 Antibody response after COVID-19 vaccine BNT162b2 on health care workers in Japan Yukihiro Yoshimura, Hiroaki Sasaki, Nobuyuki Miyata, Kazuhito Miyazaki, Natsuo Tachikawa
246 [GO] 2021―Jul―24 The influence of pre-admission antiplatelet and anticoagulation therapy on the illness severity in hospitalized patients with COVID-19 in Japan Tomiteru Togano, Yukari Uemura, Yusuke Asai, Kayoko Hayakawa, Nobuaki Matsunaga, Mari Terada, et al. (+9)
247 [GO] 2021―Jul―16 Efficacy and Safety of Hydroxychloroquine/chloroquine against SARS-CoV-2 Infection: A Systematic Review and Meta-analysis - Authors Reply Jogender Kumar, Siddharth Jain, Arushi Yadav, Jitendra Meena
248 [GO] 2021―Jul―16 Discrepancy of SARS-CoV-2 PCR results due to the sample collection sites and possible improper sampling Satoshi Irifune, Nobuyuki Ashizawa, Takahiro Takazono, Pierre Mutantu, Takeshi Nabeshima, Mya Myat Ngwe Tun, et al. (+13)
249 [GO] 2021―Jul―13 The evaluation of a novel digital immunochromatographic assay with silver amplification to detect SARS-CoV-2 Yoko Kurihara, Yoshihiko Kiyasu, Yusaku Akashi, Yuto Takeuchi, Kenji Narahara, Sunao Mori, et al. (+6)
250 [GO] 2021―Jul―08 Clinical and radiological findings of silent hypoxia among COVID-19 patients Ayako Okuhama, Masahiro Ishikane, Masatoshi Hotta, Lubna Sato, Yutaro Akiyama, Shinichiro Morioka, et al. (+6)
251 [GO] 2021―Jul―05 The estimated burden of 15 vaccine-preventable diseases from 2008 to 2020 in Japan: A transition by the COVID-19 pandemic Taito Kitano
252 [GO] 2021―Jun―25 Evaluation of false positives in the SARS-CoV-2 quantitative antigen test Ryo Kobayashi, Ryosei Murai, Mikako Moriai, Shinya Nirasawa, Hitoshi Yonezawa, Takashi Kondoh, et al. (+9)
253 [GO] 2021―Jun―12 Virological and genomic analysis of SARS-CoV-2 from a favipiravir clinical trial cohort Masahiro Suzuki, Takumi Imai, Aki Sakurai, Satoshi Komoto, Tomihiko Ide, Chang Kweng Lim, et al. (+3)
254 [GO] 2021―Jun―12 Epidemiological study using IgM and IgG antibody titers against SARS-CoV-2 in The University of Tokyo, Japan (UT-CATS) Akihisa Mitani, Kensuke Hamada, Naoyuki Yoshikawa, Yoshifumi Morita, Takeshi Horie, Yukiko Inoue, et al. (+14)
255 [GO] 2021―Jun―12 Development of a genotyping platform for SARS-CoV-2 variants using high-resolution melting analysis Akira Aoki, Yoko Mori, Yoshinori Okamoto, Hideto Jinno
256 [GO] 2021―Jun―04 Response to: Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: a systematic review and meta-analysis Lucio Boglione, Roberto Rostagno, Federica Poletti, Roberta Moglia, Bianca Bianchi, Maria Esposito, Silvio Borrè
257 [GO] 2021―May―12 Tocilizumab in COVID-19: the Cerrahpaşa-PREDICT score Ahmet Emre Eşkazan, İlker İnanç Balkan, Kaan Can Demirbaş, Muhlis Cem Ar, Rıdvan Karaali, Yonca Sekibağ, et al. (+16)
258 [GO] 2021―May―12 Does the SARS-CoV-2 rapid antigen test result correlate with the viral culture result? Kei Yamamoto, Mami Nagashima, Isao Yoshida, Kenji Sadamasu, Masami Kurokawa, Maki Nagashima, et al. (+5)
259 [GO] 2021―May―11 Scoring system for identifying Japanese patients with COVID-19 at risk of requiring oxygen supply: A retrospective single-center study Heita Kitajima, Tomonori Hirashima, Hidekazu Suzuki, Tsuyoshi Arai, Yoshitaka Tamura, Shoji Hashimoto, et al. (+7)
260 [GO] 2021―May―11 Evaluation of SARS-CoV-2 RNA quantification by RT-LAMP compared to RT-qPCR Kenta Minami, Ryota Masutani, Youichi Suzuki, Meri Kubota, Naofumi Osaka, Toyofumi Nakanishi, et al. (+2)
261 [GO] 2021―May―09 A patient with human coronavirus NL63 falsely diagnosed with COVID-19; Lesson learned for the importance of definitive diagnosis Yuki Otsuka, Hideharu Hagiya, Yasuhiro Nakano, Daisuke Omura, Kou Hasegawa, Haruto Yamada, et al. (+3)
262 [GO] 2021―Apr―24 Asymptomatic COVID-19 Re-infection in a Japanese Male by Elevated Half-Maximal Inhibitory Concentration (IC50) of Neutralizing Antibodies Makoto Inada, Masahiro Ishikane, Mari Terada, Akihiro Matsunaga, Kenji Maeda, Kiyoto Tsuchiya, et al. (+8)
263 [GO] 2021―Apr―19 Early favipiravir treatment was associated with early defervescence in non-severe COVID-19 patients Satoshi Fujii, Yuta Ibe, Tomoyuki Ishigo, Toshihiro Inamura, Yusuke Kunimoto, Yoshihiro Fujiya, et al. (+4)
264 [GO] 2021―Apr―19 Accuracy of Rapid Antigen Detection Test for Nasopharyngeal Swab Specimens and Saliva Samples in Comparison with RT-PCR and Viral Culture for SARS-CoV-2 Detection Yoshifumi Uwamino, Mika Nagata, Wataru Aoki, Terumichi Nakagawa, Rika Inose, Hiromitsu Yokota, et al. (+6)
265 [GO] 2021―Apr―16 False-positive for SARS-CoV-2 antigen test in a man with acute HIV infection Kazutaka Yamaniha, Takeshi Kinjo, Morikazu Akamine, Michika Setoguchi, Masao Tateyama, Jiro Fujita
266 [GO] 2021―Apr―15 Letter of concern re: “Immunochromatographic test for the detection of SARS-CoV-2 in saliva. J Infect Chemother. 2021 Feb;27(2):384-386. doi: 10.1016/j.jiac.2020.11.016.” Giuseppe Sberna, Eleonora Lalle, Maria Rosaria Capobianchi, Licia Bordi, Alessandra Amendola
267 [GO] 2021―Apr―13 External Validation and Update of Prediction Models for Unfavorable Outcomes in Hospitalized Patients with COVID-19 in Japan Gen Yamada, Kayoko Hayakawa, Yusuke Asai, Nobuaki Matsunaga, Hiroshi Ohtsu, Masayuki Hojo, et al. (+14)
268 [GO] 2021―Apr―08 Invasive pneumococcal disease affected the fatal outcome in a COVID-19 patient Koji Kuronuma, Naofumi Bunya, Bin Chang, Yoshihiro Fujiya, Kazunori Oishi, Eichi Narimatsu, et al. (+2)
269 [GO] 2021―Apr―08 Investigation of nasopharyngeal viral load at discharge in patients with COVID-19 Yasutaka Fukui, Hitoshi Kawasuji, Yusuke Taekgoshi, Makito Kaneda, Yushi Murai, Kou Kimoto, et al. (+6)
270 [GO] 2021―Apr―02 Efficacy and validity of automated quantitative chemiluminescent enzyme immunoassay for SARS-CoV-2 antigen test from Saliva specimen in the diagnosis of COVID-19 Nobuhiro Asai, Daisuke Sakanashi, Wataru Ohashi, Akiko Nakamura, Yuzuka Kawamoto, Narimi Miyazaki, et al. (+12)
271 [GO] 2021―Apr―02 A fatal case of COVID-19-associated invasive pulmonary aspergillosis Yuto Iwanaga, Toshinori Kawanami, Kei Yamasaki, Hideki Sakakibara, Issei Ikusima, Hiroaki Ikegami, et al. (+4)
272 [GO] 2021―Mar―29 Successful deceased donor kidney transplantation to a recipient with a history of COVID-19 treatment K. Yoshinaga, M. Araki, K. Wada, S. Sekito, T. Miyake, S. Watari, et al. (+19)
273 [GO] 2021―Mar―27 Cervical abscess caused by methicillin-susceptible Staphylococcus aureus in an infant infected with SARS-CoV-2: Diagnostic dilemma Sema Yildirim Arslan, Zumrut Sahbudak Bal, Gizem Guner Ozenen, Nimet Melis Bilen, Zafer Kurugol, Ferda Ozkinay
274 [GO] 2021―Mar―23 False positive results in severe acute respiratory coronavirus 2 (SARS-CoV-2) rapid antigen tests for inpatients Kazuhiro Itoh, Toru Kawamitsu, Yoko Osaka, Kazuyo Sato, Yusuke Suzuki, Chiyo Kiriba, et al. (+8)
275 [GO] 2021―Mar―18 Evaluation of four commercial severe acute respiratory coronavirus 2 antibody tests Nobuyuki Ashizawa, Takahiro Takazono, Kaname Ohyama, Yoji Nagasaki, Masaki Okamoto, Tatsuro Hirayama, et al. (+16)
276 [GO] 2021―Mar―12 Prolonged viral clearance of severe acute respiratory syndrome coronavirus 2 in the older aged population Akitoshi Ueno, Hitoshi Kawasuji, Yuki Miyajima, Yasutaka Fukui, Ippei Sakamaki, Mayuko Saito, et al. (+4)
277 [GO] 2021―Mar―07 Clinical Characteristics of Japanese Patients with Moderate to Severe COVID-19 Ryota Otoshi, Eri Hagiwara, Takaaki Kitayama, Takafumi Yamaya, Katsuyuki Higa, Kota Murohashi, et al. (+14)
278 [GO] 2021―Mar―07 The evaluation of a newly developed antigen test (QuickNavi™-COVID19 Ag) for SARS-CoV-2: A prospective observational study in Japan Yuto Takeuchi, Yusaku Akashi, Daisuke Kato, Miwa Kuwahara, Shino Muramatsu, Atsuo Ueda, et al. (+4)
279 [GO] 2021―Feb―26 Immunochromatography and chemiluminescent enzyme immunoassay for COVID-19 diagnosis Toshiaki ISHII, Masakazu SASAKI, Kageto YAMADA, Daiki KATO, Hiroyoshi OSUKA, Kotaro AOKI, et al. (+3)
280 [GO] 2021―Feb―26 COVID-19-associated pulmonary aspergillosis in a Japanese man: A case report Waki Imoto, Hoshi Himura, Kenji Matsuo, Sae Kawata, Ayako Kiritoshi, Ryo Deguchi, et al. (+10)
281 [GO] 2021―Feb―23 Efficacy and Safety of Hydroxychloroquine/chloroquine against SARS-CoV-2 Infection: A Systematic Review and Meta-analysis Jogender Kumar, Siddharth Jain, Jitendra Meena, Arushi Yadav
282 [GO] 2021―Feb―21 A retrospective analysis of clinical efficacy of ribavirin in adults hospitalized with severe COVID-19 Wei-Jing Gong, Tao Zhou, San-Lan Wu, Jia-Long Ye, Jia-Qiang Xu, Fang Zeng, et al. (+5)
283 [GO] 2021―Feb―21 Prevalence of thromboembolic events and status of prophylactic anticoagulant therapy in hospitalized patients with COVID-19 in Japan Sho Fujiwara, Mikio Nakajima, Richard H. Kaszynski, Kazuaki Fukushima, Masaru Tanaka, Keishiro Yajima, et al. (+9)
284 [GO] 2021―Feb―21 Factors associated with viral clearance periods from patients with COVID-19: A retrospective observational cohort study Nobuyasu Hirai, Yuichi Nishioka, Takahiro Sekine, Yuji Nishihara, Nao Okuda, Tomoko Nishimura, et al. (+12)
285 [GO] 2021―Feb―17 Predictors associated with clinical improvement of SARS-CoV-2 pneumonia Takahiro Mitsumura, Tsukasa Okamoto, Tsuyoshi Shirai, Yuki Iijima, Rie Sakakibara, Takayuki Honda, et al. (+12)
286 [GO] 2021―Feb―06 A comparison on the percentage of polymerase chain reaction positivity for SARS-CoV-2 between Public Health Center referrals and direct walk-in patients: A single center retrospective analysis in Tokyo Mikio Nakajima, Yasuhiro Yamamoto, Richard H. Kaszynski, Yuko Yamauchi, Kazuo Yamamoto, Yasushi Nakajima, et al. (+5)
287 [GO] 2021―Jan―23 Ventilator-associated bacterial pneumonia in Coronavirus 2019 disease, a retrospective monocentric cohort study Marco Moretti, Johan Van Laethem, Andrea Minini, Denis Pierard, Manu L.N.G. Malbrain
288 [GO] 2021―Jan―19 Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19 Satoshi Kutsuna, Yusuke Asai, Akihiro Matsunaga, Noriko Kinoshita, Mari Terada, Yusuke Miyazato, et al. (+10)
289 [GO] 2021―Jan―18 No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity Hidetoshi Nomoto, Satoshi Kutsuna, Kazu Okuma, Madoka Kuramitsu, Kenta Tezuka, Emi Ikebe, et al. (+10)
290 [GO] 2021―Jan―18 Evaluating a novel, highly sensitive, and quantitative reagent for detecting SARS-CoV-2 antigen Ryo Kobayashi, Ryosei Murai, Kouichi Asanuma, Yoshihiro Fujiya, Satoshi Takahashi
291 [GO] 2020―Dec―28 Suspected cholestatic liver injury induced by favipiravir in a patient with COVID-19 Shingo Yamazaki, Takaaki Suzuki, Misa Sayama, Taka-aki Nakada, Hidetoshi Igari, Itsuko Ishii
292 [GO] 2020―Dec―23 Two cases of novel coronavirus infection (COVID-19) with transient viral elevation using semi-quantitative real-time reverse transcription PCR and symptom relapse after completion of 10 days of favipiravir treatment Hajime Tsuboi, Yu Kasamatsu, Shin Matsubara, Akifumi Sasao, Katsutomo Kunimitsu, Nana Munakata, et al. (+4)
293 [GO] 2020―Dec―23 Evaluation of Clinical Utility of Novel Coronavirus Antigen Detection Reagent, Espline® SARS-CoV-2 Kotaro Aoki, Tatsuya Nagasawa, Yoshikazu Ishii, Shintaro Yagi, Katsuhito Kashiwagi, Taito Miyazaki, Kazuhiro Tateda
294 [GO] 2020―Dec―23 Immunochromatographic test for the detection of SARS-CoV-2 in saliva Katsuhito Kashiwagi, Yoshikazu Ishii, Kotaro Aoki, Shintaro Yagi, Maeda Tadashi, Taito Miyazaki, et al. (+3)
295 [GO] 2020―Dec―17 Effect of evacuation of Japanese residents from Wuhan, China, on preventing transmission of novel coronavirus infection: a modelling study Yusuke Asai, Shinya Tsuzuki, Satoshi Kutsuna, Kayoko Hayakawa, Norio Ohmagari
296 [GO] 2020―Dec―17 Prediction of an increase in oxygen requirement of SARS-CoV-2 pneumonia using three different scoring systems Tatsuya Kodama, Hirofumi Obinata, Hitoshi Mori, Wakana Murakami, Yohsuke Suyama, Hisashi Sasaki, et al. (+4)
297 [GO] 2020―Dec―05 Experience of 101 patients with Coronavirus Infectious Disease 2019 (COVID-19) at a tertiary care center in Japan Kenta Yao, Shinya Hasegawa, Yasuaki Tagashira, Akane Takamatsu, Yuki Uenoyama, Keiki Shimizu, et al. (+40)
298 [GO] 2020―Dec―04 Prolonged Viral Shedding of SARS-CoV-2 in an immunocompromised Patient Yukiko Nakajima, Asuca Ogai, Karin Furukawa, Ryosuke Arai, Ryusuke Anan, Yasushi Nakano, et al. (+4)
299 [GO] 2020―Dec―03 Clinical validation of quantitative SARS-CoV-2 antigen assays to estimate SARS-CoV-2 viral loads in nasopharyngeal swabs Kotaro Aoki, Tatsuya Nagasawa, Yoshikazu Ishii, Shintaro Yagi, Sadatsugu Okuma, Katsuhito Kashiwagi, et al. (+4)
300 [GO] 2020―Oct―31 SARS-CoV-2 detection by fluorescence loop-mediated isothermal amplification with and without RNA extraction Keisuke Taki, Isao Yokota, Tatsuya Fukumoto, Sumio Iwasaki, Shinichi Fujisawa, Masayoshi Takahashi, et al. (+9)
301 [GO] 2020―Oct―30 Analysis of a persistent viral shedding patient infected with SARS-CoV-2 by RT-qPCR, FilmArray Respiratory Panel v2.1, and antigen detection Yosuke Hirotsu, Makoto Maejima, Masahiro Shibusawa, Kenji Amemiya, Yuki Nagakubo, Kazuhiro Hosaka, et al. (+7)
302 [GO] 2020―Oct―23 Clinical characteristics of adult patients hospitalized with laboratory-confirmed COVID-19 pneumonia Elif Sargin Altunok, Mustafa Alkan, Sadettin Kamat, Berna Demirok, Celal Satici, Mustafa Asim Demirkol, et al. (+5)
303 [GO] 2020―Oct―16 Critically ill patients with COVID-19 in Tokyo, Japan: a single-center case series Satoshi Miike, Naoya Sakamoto, Takuya Washino, Atsushi Kosaka, Yusuke Kuwahara, Takuto Ishida, et al. (+5)
304 [GO] 2020―Oct―13 MuLBSTA score is a useful tool for predicting COVID-19 disease behavior Yuki Iijima, Tsukasa Okamoto, Tsuyoshi Shirai, Takahiro Mitsumura, Rie Sakakibara, Takayuki Honda, et al. (+8)
305 [GO] 2020―Oct―10 A case of COVID-19 pneumonia successfully treated with favipiravir (Avigan) in which serum SARS-CoV-2 RNA detected by LAMP method was clinically useful Takatomo Hirouchi, Shinichiro Ota, Dai Mashima, Ryuichi Boku, Yuto Yoshida, Koki Iwata, et al. (+7)
306 [GO] 2020―Oct―10 Factors significantly associated with COVID-19 severity in symptomatic patients: A retrospective single-center study Tomonori Hirashima, Tsuyoshi Arai, Heita Kitajima, Yoshitaka Tamura, Tomoki Yamada, Shoji Hashimoto, et al. (+11)
307 [GO] 2020―Oct―06 Myocardial injury in a patient with severe coronavirus disease: A case report Yuki Nakamura, Masaru Shimizu, Taeka Yamaki, Kohsuke Kushimoto, Ayahiro Yamashita, Kazuma Hayase, et al. (+3)
308 [GO] 2020―Sep―30 Comparative evaluation of nasopharyngeal swab and saliva specimens for the molecular detection of SARS-CoV-2 RNA in Japanese patients with COVID-19 Daisuke Sakanashi, Nobuhiro Asai, Akiko Nakamura, Narimi Miyazaki, Yuzuka Kawamoto, Tomoko Ohno, et al. (+14)
309 [GO] 2020―Sep―30 Severe olfactory and gustatory dysfunctions in a Japanese pediatric patient with coronavirus disease (COVID-19) Yuki Kasuga, Koji Nishimura, Hidetoshi Go, Kimitaka Nakazaki, Shoichi Shimizu, Koji Kanezawa, et al. (+3)
310 [GO] 2020―Sep―29 CT Screening for COVID-19 in Asymptomatic Patients before Hospital Admission Sho Uchida, Shunsuke Uno, Yoshifumi Uwamino, Masahiro Hashimoto, Shusuke Matsumoto, Hideaki Obara, et al. (+3)
311 [GO] 2020―Sep―10 COVID-19 Outbreak in Italy: Clinical-Radiological Presentation and Outcome in Three Oncologic Patients Davide Colombi, Flavio Cesare Bodini, Nicola Morelli, Mario Silva, Gianluca Milanese, Luigi Cavanna, Emanuele Michieletti
312 [GO] 2020―Sep―09 Could threshold cycle value correctly reflect the severity of novel coronavirus disease 2019 (COVID-19)? Nobuhiro Asai, Daisuke Sakanashi, Wataru Ohashi, Akiko Nakamura, Atsuko Yamada, Yuzuka Kawamoto, et al. (+11)
313 [GO] 2020―Sep―09 Effectiveness of Personal Protective Equipment in Preventing Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Healthcare Workers Tetsuya Suzuki, Kayoko Hayakawa, Akira Ainai, Naoko Iwata-Yoshikawa, Kaori Sano, Noriyo Nagata, et al. (+17)
314 [GO] 2020―Sep―09 Corticosteroids as adjunctive therapy in the treatment of coronavirus disease 2019: a report of two cases and literature review Makoto Kosaka, Yoshitaka Yamazaki, Takashi Maruno, Koji Sakaguchi, Shoji Sawaki
315 [GO] 2020―Sep―06 Survey of the current status of subclinical coronavirus disease 2019 (COVID-19) Ikuro Matsuba, Nobuo Hatori, Norihiko Koido, Yoshiyuki Watanabe, Futoshi Ebara, Yoko Matsuzawa, et al. (+6)
316 [GO] 2020―Sep―06 Comparison of COVID-19 Disease between Young and Elderly patients: Hidden Viral Shedding of COVID-19 Hitoshi Mori, Hirofumi Obinata, Wakana Murakami, Kodama Tatsuya, Hisashi Sasaki, Yu Miyake, et al. (+5)
317 [GO] 2020―Aug―20 Monitoring of viral load by RT-PCR caused decision making to continue ECMO therapy for a patient with COVID-19 I. Sakamaki, Y. Morinaga, H. Tani, Y. Takegoshi, Y. Fukui, H. Kawasuji, et al. (+9)
318 [GO] 2020―Aug―19 Estimated effectiveness of school closure and voluntary event cancellation as COVID-19 countermeasures in Japan Junko Kurita, Tamie Sugawara, Yasushi Ohkusa
319 [GO] 2020―Aug―06 Clinical improvement in a patient with severe coronavirus disease 2019 after administration of hydroxychloroquine and continuous hemodiafiltlation with nafamostat mesylate Sho Iwasaka, Yuji Shono, Kentaro Tokuda, Kosuke Nakashima, Yuzo Yamamoto, Jun Maki, et al. (+4)
320 [GO] 2020―Aug―05 No intrauterine vertical transmission in pregnancy with COVID-19: a case report Yantian Lv, Binbin Gu, Ying Chen, Siming Hu, Ting Ruan, Guopeng Xu, et al. (+3)
321 [GO] 2020―Jul―17 Serial serum SARS-CoV-2 RNA results in two COVID-19 cases with severe respiratory failure Tatsuya Kodama, Yuji Kouzaki, Shuichi Kawano, Hirofumi Obinata, Hiroaki Taniguchi, Hisashi Sasaki, et al. (+3)
322 [GO] 2020―Jul―01 Prolonged presence of SARS-CoV-2 in a COVID-19 case with rheumatoid arthritis taking iguratimod treated with ciclesonide Hiroaki Baba, Hajime Kanamori, Kengo Oshima, Issei Seike, Ikumi Niitsuma-Sugaya, Kentaro Takei, et al. (+3)
323 [GO] 2020―Jun―24 Incubation period of the coronavirus disease 2019 (COVID-19) in Busan, South Korea Hansol Lee, Kyungtae Kim, Kwonkyu Choi, Sangbum Hong, Hyunjin Son, Sukhyun Ryu
324 [GO] 2020―Jun―13 A case report of SARS-CoV-2 confirmed in saliva specimens up to 37 days after onset: Proposal of saliva specimens for COVID-19 diagnosis and virus monitoring Yasuhisa Tajima, Yasuo Suda, Kunio Yano
325 [GO] 2020―Jun―12 Clinical characteristics of the coronavirus disease 2019 (COVID-19) outbreak on a cruise ship Yukihiro Yoshimura, Hiroaki Sasaki, Hiroshi Horiuchi, Nobuyuki Miyata, Natsuo Tachikawa
326 [GO] 2020―May―21 Imported and locally transmitted mild SARS-CoV-2 pneumonia cases in Japan Kentaro Tochitani, Nobuki Iwamoto, Hirofumi Motobayashi, Shungo Yamamoto, Tsunehiro Shimizu
327 [GO] 2020―May―13 Clinical course of 2019 novel coronavirus disease (COVID-19) in individuals present during the outbreak on the Diamond Princess cruise ship Hideaki Kato, Hiroyuki Shimizu, Yasushi Shibue, Tomohiro Hosoda, Keisuke Iwabuchi, Kotaro Nagamine, et al. (+33)
328 [GO] 2020―May―08 Difficulty of downscaling the precautions for coronavirus disease-19 based on negative throat polymerase chain results in the early phase of infection Tetsuya Suzuki, Satoshi Kutsuna, Keiji Nakamura, Satoshi Ide, Yuki Moriyama, Sho Saito, et al. (+5)
329 [GO] 2020―Apr―18 A sporadic COVID-19 pneumonia treated with extracorporeal membrane oxygenation in Tokyo, Japan: A case report Kazuha Nakamura, Mayu Hikone, Hiroshi Shimizu, Yusuke Kuwahara, Maki Tanabe, Mioko Kobayashi, et al. (+5)
330 [GO] 2020―Apr―16 Therapeutic potential of ciclesonide inahalation for COVID-19 pneumonia: Report of three cases Keisuke Iwabuchi, Koichiro Yoshie, Yuichi Kurakami, Kota Takahashi, Yoshio Kato, Tsuneo Morishima
 [1] 

330 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.009 sec